v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net loss $ (4,249,022) $ (4,102,495)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 70,000 66,681
Amortization of right-of-use assets 96,544 131,246
Stock-based compensation 548,590 204,533
Net changes in:    
Advances, deposits, and other current assets 115,870 (84,008)
Accounts payable and accrued liabilities (567,158) 936,992
Net cash used in operating activities (3,985,176) (2,847,051)
Cash flows from investing activities:    
Purchases of property and equipment (259,652)
Net cash used in investing activities (259,652)
Cash flows from financing activities:    
Exercise of pre-funded warrants, net (1,813)
Proceeds from sale of common stock equity, net of issuance costs 105,692
Net cash (used in) provided by financing activities (1,813) 105,692
Net change in cash and cash equivalents (3,986,989) (3,001,011)
Cash and cash equivalents at beginning of period 8,781,059 5,872,767
Cash and cash equivalent at end of period $ 4,794,070 $ 2,871,756